The Federico Iovino group at Karolinska Institutet, and Therakind are initiating an exciting collaboration involving the identification of innate molecules with antimicrobial activity against antibiotic-resistant bacterial infections, with particular interest for brain infections considering the poor capability of current antibiotics to cross the blood-brain barrier.